Paid Clinical Trials in Medford, OR
As of September 2026, 29 paid clinical trials are recruiting in Medford, Oregon. Compensation typically covers time, travel, and study visits, with stipends ranging from modest amounts for short outpatient studies to several thousand dollars for long or inpatient protocols.
Medford offers studies at sites including Asante Rogue Regional Medical Center for conditions such as Anatomic Stage II Breast Cancer AJCC v8, Asthma, COPD (Chronic Obstructive Pulmonary Disease), Diabetic Peripheral Neuropathic Pain. Both patients with specific conditions and healthy volunteers can qualify. Most trials offer free study-related medical care alongside compensation.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Trials by specialty in Medford
Trials by drug in Medford
Filter results
Newly added in Medford
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
28 clinical trials
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects
Patient Retrospective Outcomes (PRO)
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
Assessment of the Safety and Efficacy of 0.1% RGN-259 Ophthalmic Solution for the Treatment of NK: SEER-2
Trial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Total Shoulder Arthroplasty Multi-Center Registry
A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty
FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC
FiberLocker® System Augmentation of Rotator Cuff Repairs
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Comparing Combinations of Drugs to Treat Newly Diagnosed Multiple Myeloma (NDMM) When a Stem Cell Transplant is Not a Medically Suitable Treatment
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Non-Squamous NSCLC
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
Top Research Study Locations in Medford
Researchers run research studies in Medford, OR at 15 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Asante Rogue Regional Medical Center | Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8 | 6 |
| Southern Oregon Orthopedics | Shoulder Arthroplasty, Chronic Pain, Pain | 4 |
| Velocity Clinical Research - Medford | Diabetic Peripheral Neuropathic Pain, Rhinovirus Infection | 3 |
| Velocity Clinical Research, Medford | Hypercholesterolemia, Plaque Psoriasis | 2 |
| Asante / Heimann Cancer Center | Non-small Cell Lung Cancer, Ovarian Cancer | 1 |
| Cataract & Laser Institute | Open-Angle Glaucoma | 1 |
| Cataract & Laser Institute of Southern Oregon | Neurotrophic Keratopathy | 1 |
| Crater Lake Surgery Center | Lumbar Spinal Stenosis | 1 |
| Enveda Investigative Site | Asthma | 1 |
| Hematology Oncology Associates | Breast Cancer | 1 |
| Pain Specialists of Southern Oregon | Chronic Pain | 1 |
| Rogue Valley Medical Center | Plasma Cell Myeloma | 1 |
| Rogue Valley Surg Ctr | Lumbar Spinal Stenosis | 1 |
| Southern Oregon Orthopedics Research Foundation | Rotator Cuff Tear, Rotator Cuff Tears, Rotator Cuff Tears of the Shoulder | 1 |
| WB Contracted Clinical Research Site | COPD (Chronic Obstructive Pulmonary Disease) | 1 |
Active & Upcoming Studies in Medford (2026)
Recruiting trials in Medford grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (10 active studies)
- ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab · Phase 3 · Alliance for Clinical Trials in Oncology
- Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response · Phase 3 · Canadian Cancer Trials Group
Neurology & pain (4 active studies)
- Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy · Phase 3 · Vertex Pharmaceuticals Incorporated
- Pivotal Study on the NOVABLOC System for Patients Undergoing Primary Total Knee Arthroplasty · Synaptrix, Inc.
Eye & vision (1 active study)
Common conditions studied in Medford
- Anatomic Stage II Breast Cancer AJCC v8 (2 active studies)
- Asthma (2 active studies)
- COPD (Chronic Obstructive Pulmonary Disease) (2 active studies)
- Diabetic Peripheral Neuropathic Pain (2 active studies)
- Non-small Cell Lung Cancer (2 active studies)
- Shoulder Arthroplasty (2 active studies)
Leading research sponsors in Medford
- AstraZeneca
- Alliance for Clinical Trials in Oncology
- Eli Lilly and Company
- Vertex Pharmaceuticals Incorporated
- Altesa Biosciences, Inc.
Frequently asked questions
How many paid clinical trials are currently recruiting in Medford?
There are approximately 29 recruiting clinical trials in Medford, Oregon listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Medford pay participants?
Most recruiting trials in Medford compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Medford?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Medford?
The most common conditions under active study in Medford include Anatomic Stage II Breast Cancer AJCC v8 (2), Asthma (2), COPD (Chronic Obstructive Pulmonary Disease) (2), Diabetic Peripheral Neuropathic Pain (2), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Medford?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Medford on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Medford?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Medford?
Recruiting research sites in Medford include Asante Rogue Regional Medical Center, Southern Oregon Orthopedics, Velocity Clinical Research - Medford, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Medford right now?
The largest active categories in Medford are Cancer & tumors (10), Neurology & pain (4), Eye & vision (1). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.